655 related articles for article (PubMed ID: 26120270)
1. Levels of selected oxidative stress markers in the vitreous and serum of diabetic retinopathy patients.
Brzović-Šarić V; Landeka I; Šarić B; Barberić M; Andrijašević L; Cerovski B; Oršolić N; Đikić D
Mol Vis; 2015; 21():649-64. PubMed ID: 26120270
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress impact on growth hormone secretion in the eye.
Šarić B; Brzović Šarić V; Barberić M; Predović J; Rumenjak V; Cerovski B
Croat Med J; 2015 Aug; 56(4):326-33. PubMed ID: 26321025
[TBL] [Abstract][Full Text] [Related]
3. Serum and intraocular concentrations of erythropoietin and vascular endothelial growth factor in patients with type 2 diabetes and proliferative retinopathy.
Semeraro F; Cancarini A; Morescalchi F; Romano MR; dell'Omo R; Ruggeri G; Agnifili L; Costagliola C
Diabetes Metab; 2014 Dec; 40(6):445-51. PubMed ID: 24878492
[TBL] [Abstract][Full Text] [Related]
4. Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study.
Fosmark DS; Bragadóttir R; Stene-Johansen I; Berg JP; Berg TJ; Lund T; Sandvik L; Hanssen KF
Acta Ophthalmol Scand; 2007 Sep; 85(6):618-22. PubMed ID: 17488318
[TBL] [Abstract][Full Text] [Related]
5. ANGPTL-4 correlates with vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
Lu Q; Zou W; Chen B; Zou C; Zhao M; Zheng Z
Graefes Arch Clin Exp Ophthalmol; 2016 Jul; 254(7):1281-8. PubMed ID: 26483143
[TBL] [Abstract][Full Text] [Related]
6. Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.
Simó R; Lecube A; Segura RM; García Arumí J; Hernández C
Am J Ophthalmol; 2002 Sep; 134(3):376-82. PubMed ID: 12208249
[TBL] [Abstract][Full Text] [Related]
7. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
Wang X; Wang G; Wang Y
Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
[TBL] [Abstract][Full Text] [Related]
8. Extracellular SOD and VEGF are increased in vitreous bodies from proliferative diabetic retinopathy patients.
Izuta H; Chikaraishi Y; Adachi T; Shimazawa M; Sugiyama T; Ikeda T; Hara H
Mol Vis; 2009 Dec; 15():2663-72. PubMed ID: 20011081
[TBL] [Abstract][Full Text] [Related]
9. Vitreous and serum levels of platelet-derived growth factor and their correlation in patients with proliferative diabetic retinopathy.
Praidou A; Klangas I; Papakonstantinou E; Androudi S; Georgiadis N; Karakiulakis G; Dimitrakos S
Curr Eye Res; 2009 Feb; 34(2):152-61. PubMed ID: 19219687
[TBL] [Abstract][Full Text] [Related]
10. Proliferative diabetic retinopathy and relations among antioxidant activity, oxidative stress, and VEGF in the vitreous body.
Izuta H; Matsunaga N; Shimazawa M; Sugiyama T; Ikeda T; Hara H
Mol Vis; 2010 Jan; 16():130-6. PubMed ID: 20142849
[TBL] [Abstract][Full Text] [Related]
11. The effect of a systemic angiotensin receptor blocker on vascular endothelial growth factor in the vitreous of patients with proliferative diabetic retinopathy.
Byon IS; Jeon HS; Kim HW; Lee SJ; Lee JE; Oum BS
Curr Eye Res; 2013 Jul; 38(7):774-80. PubMed ID: 23725216
[TBL] [Abstract][Full Text] [Related]
12. CORRELATION OF INCREASED INTRAVITREOUS WNT3A WITH VASCULAR ENDOTHELIAL GROWTH FACTOR IN PROLIFERATIVE DIABETIC RETINOPATHY.
Gao X; Ma K; Lu N; Hong T; Xu Y; Peng X
Retina; 2016 Apr; 36(4):812-8. PubMed ID: 26418446
[TBL] [Abstract][Full Text] [Related]
13. Elevated LRP6 levels correlate with vascular endothelial growth factor in the vitreous of proliferative diabetic retinopathy.
Gao X; Ma K; Lu N; Xu Y; Hong T; Peng X
Mol Vis; 2015; 21():665-72. PubMed ID: 26120271
[TBL] [Abstract][Full Text] [Related]
14. Relationships between vitreous levels of soluble receptor for advanced glycation end products (sRAGE) and renal function in patients with diabetic retinopathy.
Katagiri M; Shoji J; Kato S; Kitano S; Uchigata Y
Int Ophthalmol; 2017 Dec; 37(6):1247-1255. PubMed ID: 27830398
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor levels in vitreous and serum of patients with either proliferative diabetic retinopathy or proliferative vitreoretinopathy.
Sydorova M; Lee MS
Ophthalmic Res; 2005; 37(4):188-90. PubMed ID: 15990461
[TBL] [Abstract][Full Text] [Related]
16. Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control study.
Hernández C; Burgos R; Cantón A; García-Arumí J; Segura RM; Simó R
Diabetes Care; 2001 Mar; 24(3):516-21. PubMed ID: 11289478
[TBL] [Abstract][Full Text] [Related]
17. Diabetes-induced oxidative stress in the vitreous humor.
Géhl Z; Bakondi E; Resch MD; Hegedűs C; Kovács K; Lakatos P; Szabó A; Nagy Z; Virág L
Redox Biol; 2016 Oct; 9():100-103. PubMed ID: 27454767
[TBL] [Abstract][Full Text] [Related]
18. Assessment of neuron-specific enolase, S100B and malondialdehyde levels in serum and vitreous of patients with proliferative diabetic retinopathy.
Asadova V; Gul Z; Buyukuysal RL; Yalcinbayir O
Int Ophthalmol; 2020 Jan; 40(1):227-234. PubMed ID: 31571092
[TBL] [Abstract][Full Text] [Related]
19. Lipid peroxidation in proliferative vitreoretinopathies.
Verdejo C; Marco P; Renau-Piqueras J; Pinazo-Duran MD
Eye (Lond); 1999 Apr; 13 ( Pt 2)():183-8. PubMed ID: 10450379
[TBL] [Abstract][Full Text] [Related]
20. Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy.
Burgos R; Simó R; Audí L; Mateo C; Mesa J; García-Ramírez M; Carrascosa A
Diabetologia; 1997 Sep; 40(9):1107-9. PubMed ID: 9300249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
